A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation

Trial Profile

A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2015

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Myocardial infarction; Stroke; Thromboembolism
  • Focus Registrational; Therapeutic Use
  • Acronyms ACTIVE; ACTIVE-A
  • Sponsors Sanofi
  • Most Recent Events

    • 05 Apr 2011 Combined results from this study and the AVERROES study presented at the 60th Annual Scientific Session of the American College of Cardiology.
    • 14 Nov 2009 Results presented at the 82nd Annual Scientific Sessions of the American Heart Association (AHA 2009).
    • 14 Apr 2009 Planned number of patients changed from 7500 to 7554 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top